CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,209,843
- in 4 filings, $2.2M under 10b5-1 plans
Net −$5,209,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +58,300 | $24.16 | $1.4M | 5,825,521 |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +310,700 | $23.67 | $7.4M | 5,767,221 |
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +6,200 | 6,200 | ||
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +8,300 | 8,300 | ||
| 2025-09-04 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,176,470 | $25.50 | $30.0M | 5,456,521 |
| 2025-03-13 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,296,296 | $13.50 | $17.5M | 4,280,051 |
| 2025-02-13 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +32,900 | 32,900 | ||
| 2024-05-22 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2024-02-12 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +1,672,508 | $13.50 | $22.6M | 2,983,755 |
| 2024-02-12 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Pre-Funded Warrants (Right to Buy) | +549,755 | $13.50 | $7.4M | 549,755 |
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +1,735,629 | 1,735,629 | ||
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +131,600 | $16.00 | $2.1M | 1,867,229 |
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +192,847 | 192,847 | ||
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,118,400 | $16.00 | $17.9M | 1,311,247 |
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −1,735,629 | 0 | ||
| 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −192,847 | 0 | ||
| 2023-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option | +44,000 | 44,000 |
Page 1 of 1 · 17 trades